Ethyl acrylate
| Names | |
|---|---|
| Preferred IUPAC name
Ethyl prop-2-enoate | |
| Other names
Ethyl propenoate Ethyl acrylate Acrylic acid ethyl ester Ethyl ester of acrylic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.004.945 |
| EC Number |
|
| KEGG | |
PubChem CID |
|
| RTECS number |
|
| UNII | |
| UN number | 1917 |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C5H8O2 | |
| Molar mass | 100.117 g·mol−1 |
| Appearance | Colorless liquid |
| Odor | Acrid |
| Density | 0.9405 g/mL |
| Melting point | −71 °C (−96 °F; 202 K) |
| Boiling point | 99.4 °C (210.9 °F; 372.5 K) |
| 1.5 g/100 mL | |
| Solubility | organic solvents |
| Vapor pressure | 29 mmHg (20°C) |
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
Main hazards |
Carcinogenic |
| GHS labelling: | |
| Danger | |
| H225, H302, H312, H315, H317, H319, H332, H335 | |
| P210, P233, P240, P241, P242, P243, P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P303+P361+P353, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P333+P313, P337+P313, P362, P363, P370+P378, P403+P233, P403+P235, P405, P501 | |
| NFPA 704 (fire diamond) | |
| Flash point | 15 °C (59 °F; 288 K) |
| Explosive limits | 1.4%-14% |
| Lethal dose or concentration (LD, LC): | |
LC50 (median concentration) |
2180 ppm (rat, 4 hr) 3894 ppm (mouse) |
LCLo (lowest published) |
1204 ppm (rabbit, 7 hr) 1204 ppm (guinea pig, 7 hr) |
| NIOSH (US health exposure limits): | |
PEL (Permissible) |
TWA 25 ppm (100 mg/m3) [skin] |
REL (Recommended) |
Carcinogen |
IDLH (Immediate danger) |
Ca [300 ppm] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Ethyl acrylate is an organic compound with the formula CH2CHCO2CH2CH3. It is the ethyl ester of acrylic acid. It is a colourless liquid with a characteristic acrid odor. It is mainly produced for paints, textiles, and non-woven fibers. It is also a reagent in the synthesis of various pharmaceutical intermediates.